Chen Ke, Tong Qin, Yan Jia-Fei, Huang Chao-Jie, Pan Yu, Zhang Ren-Chao, Chen Qi-Long, Zheng Xue-Yong, Cai Xiao-Yan, Wang Yong, Wang Xian-Fa
Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University, 3 East Qingchun Road, Hangzhou, 310016, Zhejiang, China.
School of Medicine, Zhejiang University, 866 Yuhangtang Road, Hangzhou, 310058, Zhejiang, China.
Updates Surg. 2020 Jun;72(2):387-397. doi: 10.1007/s13304-020-00742-5. Epub 2020 Apr 8.
Laparoscopic distal pancreatectomy (LDP) for benign and low-grade malignant pancreatic diseases has been increasingly utilized. However, the use of LDP for pancreatic ductal adenocarcinoma (PDAC) remains controversial and has not been widely accepted. In this study, the outcomes of LDP versus conventional open distal pancreatectomy (ODP) for left-sided PDAC were examined. A retrospective review of patients who underwent LDP or ODP for left-sided PDAC between January 2010 and January 2019 was conducted. One-to-one propensity score matching (PSM) was used to minimize selection biases by balancing factors including age, sex, ASA grade, tumor size, and combined resection. Demographic data, their pathological and short-term clinical parameters, and long-term oncological outcomes were compared between the LDP and ODP groups. A total of 197 patients with PDAC were enrolled. There were 115 (58.4%) patients in the LDP group and 82 (41.6%) patients in the ODP group. After 1:1 PSM, 66 well-matched patients in each group were evaluated. The LDP group had lesser blood loss (195 vs. 210 mL, p < 0.01), shorter operative time (193.6 vs. 217.5 min; p = 0.02), and shorter hospital stay (12 vs. 15 days, p < 0.01), whereas the overall complication rates were comparable between groups (10.6% vs.16.7%, p = 0.31). There were no significant differences between the LDP and ODP groups regarding 3-year recurrence-free or overall survival rate (p = 0.89 and p = 0.33, respectively). LDP in the treatment of left-sided PDAC is a technically safe, feasible and favorable approach in short-term surgical outcomes. Moreover, patients undergoing LDP than ODP for PDAC had comparable oncological metrics and similar middle-term survival rate.
腹腔镜远端胰腺切除术(LDP)在良性及低级别恶性胰腺疾病中的应用越来越广泛。然而,LDP用于胰腺导管腺癌(PDAC)仍存在争议,尚未被广泛接受。在本研究中,对LDP与传统开放性远端胰腺切除术(ODP)治疗左侧PDAC的疗效进行了研究。回顾性分析了2010年1月至2019年1月期间接受LDP或ODP治疗左侧PDAC的患者。采用一对一倾向评分匹配(PSM),通过平衡年龄、性别、美国麻醉医师协会(ASA)分级、肿瘤大小和联合切除术等因素来尽量减少选择偏倚。比较了LDP组和ODP组的人口统计学数据、病理及短期临床参数以及长期肿瘤学结局。共纳入197例PDAC患者。LDP组有115例(58.4%),ODP组有82例(41.6%)。经过1:1 PSM后,对每组66例匹配良好的患者进行了评估。LDP组失血量较少(195 vs. 210 mL,p<0.01),手术时间较短(193.6 vs. 217.5分钟;p = 0.02),住院时间较短(12 vs. 15天,p<0.01),而两组的总体并发症发生率相当(10.6% vs. 16.7%,p = 0.31)。LDP组和ODP组在3年无复发生存率或总生存率方面无显著差异(分别为p = 0.89和p = 0.33)。LDP治疗左侧PDAC在短期手术结局方面是一种技术上安全、可行且良好的方法。此外,PDAC患者接受LDP治疗与接受ODP治疗相比,肿瘤学指标相当,中期生存率相似。